🔴 Context Therapeutics is trading 6% down today with no clear catalyst identified

Context Therapeutics is trading 6% down at $0.58 in after-hours trading, retreating from its recent $0.61 regular-session close.

• The move comes without any fresh, widely reported company-specific news.
• The decline likely reflects normal after-hours volatility in a low-priced, thinly traded stock rather than a clear fundamental catalyst.